Personalized medicine and access to health care: potential for inequitable access?

[1]  L. Ross.  Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit , 2012 .

[2]  Ammarin Thakkinstian,et al.  Risk prediction models of breast cancer: a systematic review of model performances , 2012, Breast Cancer Research and Treatment.

[3]  Richard D. Riley,et al.  A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance , 2012, Breast Cancer Research and Treatment.

[4]  A. LaCroix,et al.  Evaluating breast cancer risk projections for Hispanic women , 2012, Breast Cancer Research and Treatment.

[5]  Geoffrey S Ginsburg,et al.  Personalized medicine: progress and promise. , 2011, Annual review of genomics and human genetics.

[6]  Julie O. Culver,et al.  Genetics, genomics, and cancer risk assessment , 2011, CA: a cancer journal for clinicians.

[7]  J. Barrett,et al.  Genetic risk prediction in complex disease , 2011, Human molecular genetics.

[8]  D. English,et al.  A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact , 2011, Genetic epidemiology.

[9]  Francisco M. De La Vega,et al.  Genomics for the world , 2011, Nature.

[10]  M. Greene,et al.  A stratified genetic risk assessment for testicular cancer. , 2011, International journal of andrology.

[11]  M. Guyer,et al.  Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.

[12]  Y. Joly,et al.  Genetic discrimination in private insurance: global perspectives , 2010 .

[13]  B. Knoppers,et al.  Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine? , 2010, Genetics in Medicine.

[14]  Charalabos-Markos Dintsios,et al.  Information on ethical issues in health technology assessment: How and where to find them , 2010, International Journal of Technology Assessment in Health Care.

[15]  Muin J Khoury,et al.  Family history and personal genomics as tools for improving health in an era of evidence-based medicine. , 2010, American journal of preventive medicine.

[16]  D. Evans,et al.  Assessing women at high risk of breast cancer: a review of risk assessment models. , 2010, Journal of the National Cancer Institute.

[17]  E. Borden,et al.  Personalizing medicine for cancer: the next decade , 2010, Nature Reviews Drug Discovery.

[18]  R. Schilsky.  Personalized medicine in oncology: the future is now , 2010, Nature Reviews Drug Discovery.

[19]  Alexander A. Morgan,et al.  Clinical assessment incorporating a personal genome , 2010, The Lancet.

[20]  S. Duffy,et al.  Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project , 2010, Cancer Prevention Research.

[21]  S. Aydintuǧ,et al.  Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor , 2010, Breast Cancer Research and Treatment.

[22]  Muin J. Khoury,et al.  Family history in public health practice: a genomic tool for disease prevention and health promotion. , 2010, Annual review of public health.

[23]  M. Pike,et al.  National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. , 2010, Journal of the National Cancer Institute.

[24]  A. Kurian.  BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications , 2010, Current opinion in obstetrics & gynecology.

[25]  Robert A Hiatt,et al.  National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. , 2009, Annals of internal medicine.

[26]  W. McCaskill-Stevens,et al.  Breast Cancer Risk Assessments Comparing Gail and CARE Models in African‐American Women , 2009, The breast journal.

[27]  Kimberly M. Kelly,et al.  How Can We Reach Them? Information Seeking and Preferences for a Cancer Family History Campaign in Underserved Communities , 2009, Journal of health communication.

[28]  Robert A Hiatt,et al.  National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health: August 24-26, 2009. , 2009, NIH consensus and state-of-the-science statements.

[29]  P. Raina,et al.  The current state of cancer family history collection tools in primary care: a systematic review , 2009, Genetics in Medicine.

[30]  Muin J. Khoury,et al.  Challenges of translating genetic tests into clinical and public health practice , 2009, Nature Reviews Genetics.

[31]  Wendy Zukerman.  Genetic discrimination in the workplace: towards legal certainty in uncertain times. , 2009, Journal of law and medicine.

[32]  Christi J. van Asperen,et al.  Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? , 2009, Breast Cancer Research and Treatment.

[33]  A. Whittemore,et al.  Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family Registry , 2009, Cancer Epidemiology Biomarkers & Prevention.

[34]  D. Miglioretti,et al.  Accuracy of self-reported breast cancer among women undergoing mammography , 2009, Breast Cancer Research and Treatment.

[35]  A. Kroon,et al.  Obtaining the family history for common, multifactorial diseases by family physicians. A descriptive systematic review , 2009, The European journal of general practice.

[36]  M. Rothstein.  Currents in Contemporary Ethics GINA, the ADA, and Genetic Discrimination in Employment , 2008, Journal of Law, Medicine & Ethics.

[37]  R. Vierkant,et al.  Assessment of the accuracy of the Gail model in women with atypical hyperplasia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  G. Guyatt,et al.  Progress in evidence-based medicine. , 2008, JAMA.

[39]  V. Entwistle,et al.  Guidance for considering ethical, legal, and social issues in health technology assessment: Application to genetic screening , 2008, International Journal of Technology Assessment in Health Care.

[40]  V. Entwistle,et al.  Ethical, Legal, and Social Issues in Health Technology Assessment for Prenatal/Preconceptional and Newborn Screening: A Workshop Report , 2008, Public Health Genomics.

[41]  S. Terry,et al.  Healthy Choices through Family History: A Community Approach to Family History Awareness , 2008, Public Health Genomics.

[42]  K. Calzone,et al.  Genetic testing for cancer susceptibility. , 2008, The Surgical clinics of North America.

[43]  R. Eeles,et al.  Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics , 2008, Journal of Medical Genetics.

[44]  K. Majidzadeh-A,et al.  Breast cancer risk assessment by Gail model in Iranian patients: accuracy and limitations , 2008 .

[45]  S. Kjaer,et al.  Accuracy of self-reported family history of cancer in a large case–control study of ovarian cancer , 2008, Cancer Causes & Control.

[46]  Sarkis Meterissian,et al.  Canadian Association of General Surgeons and American College of Surgeons Evidence Based Reviews in Surgery. 23. ASCO recommended guidelines for sentinel lymph node biopsy for early-stage breast cancer. Evidence-based medicine. A new approach to teaching the practice of medicine. , 2007, Canadian journal of surgery. Journal canadien de chirurgie.

[47]  M. Khoury,et al.  The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? , 2007, Genetics in Medicine.

[48]  Richard G. Hamermesh,et al.  Realizing the promise of personalized medicine. , 2007, Harvard business review.

[49]  Marc S Williams,et al.  Rapid ACCE: Experience with a rapid and structured approach for evaluating gene-based testing , 2007, Genetics in Medicine.

[50]  S. Cummings,et al.  Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.

[51]  K. Hudson.  Prohibiting genetic discrimination. , 2007, The New England journal of medicine.

[52]  Barbara L. Smith,et al.  Accuracy of Self-Reported Personal History of Cancer in an Outpatient Breast Center , 2007, Journal of Genetic Counseling.

[53]  E. Bates.  The United Kingdom and the International Covenant on Economic, Social and Cultural Rights , 2007 .

[54]  David L. Sackett,et al.  Evidence based medicine: What it is and what it isn't (reprinted from BMJ, vol 312, pg 71-72, 1996) , 2007 .

[55]  Stefano Calza,et al.  Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. , 2006, Journal of the National Cancer Institute.

[56]  A. Maradiegue,et al.  An overview of ethnicity and assessment of family history in primary care settings , 2006, Journal of the American Academy of Nurse Practitioners.

[57]  Nabil Amara,et al.  The knowledge-value chain: A conceptual framework for knowledge translation in health. , 2006, Bulletin of the World Health Organization.

[58]  Lincoln Quillian,et al.  NEW APPROACHES TO UNDERSTANDING RACIAL PREJUDICE AND DISCRIMINATION , 2006 .

[59]  W. Zheng,et al.  Impact of patient age on family cancer history , 2006, Genetics in Medicine.

[60]  M. FloodColleen.  Just Medicare: What's In, What's Out, How We Decide , 2006 .

[61]  D. Easton,et al.  BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families , 2005, Breast Cancer Research.

[62]  J. Emery,et al.  How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom , 2005, Genetics in Medicine.

[63]  H. Murff,et al.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. , 2004, JAMA.

[64]  Adopted on March.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  G. Ginsburg,et al.  The path to personalized medicine. , 2002, Current opinion in chemical biology.

[66]  K. Hughes,et al.  The Effectiveness of the Gail Model in Estimating Risk for Development of Breast Cancer in Women Under 40 Years of Age , 2001, The breast journal.

[67]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[68]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[69]  T. Beauchamp,et al.  Principles of biomedical ethics , 1991 .

[70]  W. Burke,et al.  Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit , 2011 .

[71]  F. Lalloo,et al.  Development of a scoring system to screen for BRCA1/2 mutations. , 2010, Methods in molecular biology.

[72]  Z. Miedzybrodzka,et al.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models , 2007, Familial Cancer.

[73]  N. Choudhry.  Just Medicare What ’ s In , What ’ s Out , How We Decide , 2006 .

[74]  T. Brennan,et al.  Race and family history assessment for breast cancer , 2005, Journal of general internal medicine.

[75]  J. Gevers,et al.  Health law, human rights and the Biomedicine Convention : essays in honour of Henriette Roscam Abbing , 2005 .

[76]  Aart Hendriks,et al.  Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. , 2000, The Journal of medicine and philosophy.

[77]  M R Natowicz,et al.  Discrimination as a consequence of genetic testing. , 1992, American journal of human genetics.